Abstract:ID 129693 Poster Board 492 Animal testing for drug discovery is expensive and the decision to test a compound in an animal model should be carefully considered. In addition, the FDA Modernization Act has resulted in the allowance of alternatives to animal models for testing the safety and efficacy of drug candidates. Among these alternatives are human tissue models that provide a human-relevant context. Specialized cell types can be produced from primary human cells and used for basic research and drug discovery purposes. One of these is a 3D model for respiratory disease research, consisting of human-derived tracheal/bronchial epithelial cells. Though this translational Human Airway Epithelial (HAE) model is currently being employed by many researchers, this work is primarily done using individual tissue inserts placed in 6-well plates. This low-throughput approach is labor-intensive, time-consuming and expensive (high cost per each compound screened). We have established a high-throughput HAE assay that can be used for compound screening to advance respiratory virus programs. This is significant as it allows a higher number of compounds to be evaluated before being tested in vivo, allowing a more comprehensive comparison of candidates at this later discovery stage. We developed 96-well assays to evaluate compounds for Influenza, Respiratory Syncytial Virus (RSV) and Coronaviruses (including BSL-3 strains such as SARS-CoV-2), and these assays are easily adaptable to other respiratory viruses like Human metapneumovirus (HMPV). The development process involved performing a titration of each virus for TCID 50 calculations and determining the optimal HAE infection time in a time course experiment, with every step of the process automated to increase speed and accuracy. Following infection of the HAE tissues, the amount of infectious virus in HAE supernatant was assessed in a Cytopathic Effect (CPE) or Virus Titer Reduction (VTR) assay in an appropriate cell line for that particular virus. The optimized assays consistently showed Z' values > 0.7 and were used to test reference compounds relevant to each antiviral assay. The assay development process and representative results for H3N2 A/Udorn/72 and RSV Long strain will be presented to highlight the benefits of miniaturizing HAE assays from individual wells into a 96-well format, thereby providing a high-throughput solution for human 3D in vitro respiratory tissue models. State of Alabama Innovation Fund (Project number 15803.12.01)

Development of a miniaturized 96-Transwell air–liquid interface human small airway epithelial model

Transwell Insert-Embedded Microfluidic Devices for Time-Lapse Monitoring of Alveolar Epithelium Barrier Function under Various Stimulations

A novel in vitro tubular model to recapitulate features of distal airways: the bronchioid

A Modular Human Airway Lung‐Chip for Studying the Effect of Breathing‐Mechanics on Airway Epithelial Cell Biology

A miniaturized multicellular platform to mimic the 3D structure of the alveolar-capillary barrier

Small molecule-directed differentiation of submerged-cultured human nasal airway epithelia for respiratory disease modelling

Air-Liquid Interface Cultures to Model Drug Delivery Through the Mucociliary Epithelial Barrier.

Development of an in vitro human alveolar epithelial air-liquid interface model using a small molecule inhibitor cocktail

Development of human alveolar epithelial cell models to study distal lung biology and disease

Collagen Tubular Airway‐on‐Chip for Extended Epithelial Culture and Investigation of Ventilation Dynamics

Lung-on-a-chip with a Biological, Stretchable Membrane: New Generation of In-Vitro Air-Blood Barrier Model

Development of a multi-analysis model using an epithelial-fibroblast co-culture system as an alternative to animal testing

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

Characterization of Commercially Available Human Primary Alveolar Epithelial Cells

Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures

In vitro Methods for the Development and Analysis of Human Primary Airway Epithelia

A High-Throughput Human Tissue Model for Respiratory Viruses

A Microfluidic Lung-on-a-chip Based on Biomimetic Hydrogel Membrane

An air-liquid interface model of human lung epithelium generated from bronchiolar epithelial cells proliferated using medium containing ROCK kinase inhibitor

Revolutionizing Epithelial Differentiability Analysis in Small Airway-on-a-Chip Models Using Label-Free Imaging and Computational Techniques